Danielle Enserro

4.0k total citations · 1 hit paper
48 papers, 1.7k citations indexed

About

Danielle Enserro is a scholar working on Cardiology and Cardiovascular Medicine, Reproductive Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Danielle Enserro has authored 48 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 11 papers in Reproductive Medicine and 9 papers in Obstetrics and Gynecology. Recurrent topics in Danielle Enserro's work include Ovarian cancer diagnosis and treatment (11 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Danielle Enserro is often cited by papers focused on Ovarian cancer diagnosis and treatment (11 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Danielle Enserro collaborates with scholars based in United States, Germany and Canada. Danielle Enserro's co-authors include Ramachandran S. Vasan, Vanessa Xanthakis, Martin G. Larson, John S. Gottdiener, Connie W. Tsao, Bruce M. Psaty, Jorge R. Kizer, Asya Lyass, Jennifer E. Ho and Thomas J. Wang and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Danielle Enserro

45 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction

2018 361 citations Connie W. Tsao, Asya Lyass et al. JACC Heart Failure profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Danielle Enserro United States	21	948	221	185	173	157	48	1.7k
Bernhard M. Kaess Germany	20	1.3k 1.4×	288 1.3×	283 1.5×	40 0.2×	237 1.5×	62	2.1k
Natalie Daya United States	24	617 0.7×	347 1.6×	246 1.3×	85 0.5×	391 2.5×	67	1.9k
Beste Özben Türkiye	20	857 0.9×	221 1.0×	87 0.5×	63 0.4×	156 1.0×	110	1.6k
Galen Cook‐Wiens United States	20	538 0.6×	393 1.8×	115 0.6×	37 0.2×	122 0.8×	88	1.4k
Vicente Álvarez Spain	22	1.1k 1.1×	457 2.1×	155 0.8×	95 0.5×	99 0.6×	46	2.2k
Sandra Fedi Italy	26	582 0.6×	408 1.8×	108 0.6×	185 1.1×	156 1.0×	78	1.9k
I. C. D. Westendorp Netherlands	16	514 0.5×	342 1.5×	79 0.4×	210 1.2×	340 2.2×	23	1.6k
Faye L. Lopez United States	25	1.9k 2.0×	221 1.0×	227 1.2×	127 0.7×	265 1.7×	46	2.6k
Markus Kosch Germany	23	782 0.8×	253 1.1×	135 0.7×	78 0.5×	55 0.4×	59	1.6k
Andrea Zuckerman United States	18	622 0.7×	790 3.6×	248 1.3×	136 0.8×	151 1.0×	32	2.4k

Countries citing papers authored by Danielle Enserro

Since Specialization

Citations

This map shows the geographic impact of Danielle Enserro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Enserro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Enserro more than expected).

Fields of papers citing papers by Danielle Enserro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danielle Enserro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Enserro. The network helps show where Danielle Enserro may publish in the future.

Co-authorship network of co-authors of Danielle Enserro

This figure shows the co-authorship network connecting the top 25 collaborators of Danielle Enserro. A scholar is included among the top collaborators of Danielle Enserro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danielle Enserro. Danielle Enserro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mazza, Gina L., et al.. (2025). Design and analysis considerations for investigating patient subgroups of interest within cancer clinical trials. JNCI Monographs. 2025(68). 22–29. 1 indexed citations

Enserro, Danielle, et al.. (2025). Challenges to and considerations of designing cancer prevention trials. JNCI Monographs. 2025(68). 49–55.

Unger, Joseph M., Gina L. Mazza, Mohamed I. Elsaid, et al.. (2025). When to adjust for multiplicity in cancer clinical trials. JNCI Monographs. 2025(68). 3–9. 1 indexed citations

Klopp, Ann H., Danielle Enserro, Matthew A. Powell, et al.. (2024). Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial. Journal of Clinical Oncology. 42(20). 2425–2435. 10 indexed citations

Erickson, Britt, Danielle Enserro, Heather A. Lankes, et al.. (2024). Phase II/III study of paclitaxel/carboplatin alone or combined with either trastuzumab and hyaluronidase-oysk or pertuzumab, trastuzumab, and hyaluronidase-zzxf in HER2 positive, stage I-IV endometrial serous carcinoma or carcinosarcoma (NRG-GY026).. Journal of Clinical Oncology. 42(16_suppl). TPS5641–TPS5641. 4 indexed citations

Gien, Lilian T., Danielle Enserro, Matthew S. Block, et al.. (2024). Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016. Gynecologic Oncology. 186. 61–68. 10 indexed citations

Rimel, B.J., Danielle Enserro, David Bender, et al.. (2023). NRG‐GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer. Cancer. 130(8). 1234–1245. 6 indexed citations

Clements, Aine, Danielle Enserro, Kyle C. Strickland, et al.. (2023). SO018/#362 Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) outcomes: ancillary analysis of GOG-0258. A23–A23. 4 indexed citations

Vasan, Ramachandran S., Danielle Enserro, Alexa Beiser, & Vanessa Xanthakis. (2022). Lifetime Risk of Heart Failure Among Participants in the Framingham Study. Journal of the American College of Cardiology. 79(3). 250–263. 36 indexed citations

10.

Enserro, Danielle, Robert A. Burger, Mark F. Brady, et al.. (2021). Correlation of imaging and plasma based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC). Gynecologic Oncology. 161(2). 382–388. 10 indexed citations

11.

Silva, Diane M. Da, Danielle Enserro, Jyoti Mayadev, et al.. (2020). Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929). Clinical Cancer Research. 26(21). 5621–5630. 54 indexed citations

12.

Velagaleti, Raghava S., Martin G. Larson, Danielle Enserro, Rebecca J. Song, & Ramachandran S. Vasan. (2020). Clinical Course After a First Episode of Heart Failure: Insights from the Framingham Heart Study. European Journal of Heart Failure. 22(10). 1768–1776. 7 indexed citations

13.

Spirtos, Nick M., Danielle Enserro, Howard D. Homesley, et al.. (2019). The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced endometrial cancer (EC): A randomized phase III NRG/Gynecologic Oncology Group (GOG) study. Gynecologic Oncology. 154(1). 13–21. 11 indexed citations

14.

Tsao, Connie W., Asya Lyass, Danielle Enserro, et al.. (2018). Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction. JACC Heart Failure. 6(8). 678–685. 361 indexed citations breakdown →

15.

Nayor, Matthew, Danielle Enserro, Vanessa Xanthakis, et al.. (2018). Comorbidities and Cardiometabolic Disease. JACC Heart Failure. 6(4). 317–325. 24 indexed citations

16.

Hensley, Martee L., Danielle Enserro, Helen Hatcher, et al.. (2018). Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for uterus-limited, high-grade leiomyosarcoma: A phase III GOG study.. Journal of Clinical Oncology. 36(15_suppl). 5505–5505. 6 indexed citations

17.

Nayor, Matthew, Leroy L. Cooper, Danielle Enserro, et al.. (2018). Left Ventricular Diastolic Dysfunction in the Community: Impact of Diagnostic Criteria on the Burden, Correlates, and Prognosis. Journal of the American Heart Association. 7(11). 47 indexed citations

18.

Puurunen, Marja, Danielle Enserro, Vanessa Xanthakis, et al.. (2016). Biomarkers for the prediction of venous thromboembolism in the community. Thrombosis Research. 145. 34–39. 13 indexed citations

19.

Cheng, Susan, Danielle Enserro, Vanessa Xanthakis, et al.. (2014). Association of exhaled carbon monoxide with subclinical cardiovascular disease and their conjoint impact on the incidence of cardiovascular outcomes. European Heart Journal. 35(42). 2980–2987. 19 indexed citations

20.

Kaess, Bernhard M., Danielle Enserro, David D. McManus, et al.. (2012). Cardiometabolic Correlates and Heritability of Fetuin-A, Retinol-Binding Protein 4, and Fatty-Acid Binding Protein 4 in the Framingham Heart Study. The Journal of Clinical Endocrinology & Metabolism. 97(10). E1943–E1947. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact